Modifiers of Beta-Amyloid Metabolism and Deposition in Mouse Models of Alzheimer’S Disease

Total Page:16

File Type:pdf, Size:1020Kb

Modifiers of Beta-Amyloid Metabolism and Deposition in Mouse Models of Alzheimer’S Disease MODIFIERS OF BETA-AMYLOID METABOLISM AND DEPOSITION IN MOUSE MODELS OF ALZHEIMER’S DISEASE by STEFANIE SCHRUMP Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Dissertation Adviser: Bruce Lamb, Ph.D. Department of Genetics CASE WESTERN RESERVE UNIVERSITY August, 2011 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Stefanie Elaine Schrump______________________________________ candidate for the Doctor of Philosophy degree *. (signed) Mitch Drumm_______________________________________ (chair of the committee) Bruce Lamb_________________________________________ Anna Mitchell_______________________________________ Gary Landreth_______________________________________ ___________________________________________________ (date) May 9, 2011____________ *We also certify that written approval has been obtained for any proprietary material contained therein. 2 Copyright © 2011 by Stefanie E. Schrump All rights reserved 3 This thesis is dedicated to my children, the greatest accomplishments of my life. 4 TABLE OF CONTENTS Chapter 1: Introduction and Research Aims………………………………….16 Introduction to Alzheimer’s Disease Alzheimer’s Disease Hallmarks Alzheimer’s Disease Epidemiology APP, Abeta and the Amyloid Hypothesis Mouse Models of Alzheimer’s Disease Research Aims Chapter 2: Gene-Environment Interactions Influence Beta-Amyloid Metabolism in Mice…………………………………………………..60 Abstract Introduction Materials and Methods Results Discussion Chapter 3: The Role of the Complement Protein C5 Signaling in Beta- Amyloid Deposition………………………………………………...117 Abstract Introduction Materials and Methods Results Discussion 5 Chapter 4: Genetic Background Differentially Influences Beta-Amyloid Metabolism and Deposition……………………………………….154 Abstract Introduction Materials and Methods Results Discussion Chapter 5: Summary and Future Directions…………………………………195 Summary Observation 1: Genetic background alters Aβ levels Observation 2: Genes and environment interact to alter Aβ levels Observation 3: Identification of chromosomal loci associated with altered Aβ levels Conclusions Bibliography…………………………………………………………………………209 6 LIST OF TABLES: Chapter 1: Table 1-1: Genes showing genome-wide significance in at least one GWAS……………………………………………………...52 Table 1-2: Current top nine genes, in addition to APOE, associated with Alzheimer’s disease based on meta-analysis of published association studies………………………………...53 Table 1-3: Selected examples of mouse models of Alzheimer’s disease………………………………………………………….58 Table 1-4: Summary of studies examining the effects of HF/HC diet on mouse models of AD………………………………………59 Chapter 2: Table 2-1: Genes exhibiting altered expression on HF/HC diets …………………………………………………………...103 Supplemental Table 2-1: 159 genes differentially expressed in HF/HC fed B6-R1.40 animals……………………………….112 Supplemental Table 2-2: 6 genes differentially expressed in HF/HC- fed 129-R1.40 animals……………………………………....116 7 LIST OF FIGURES Chapter 1: Figure 1-1: Genetic and environmental factors influence AD risk……………………………………………………………….50 Figure 1-2: Processing of the amyloid precursor protein (APP)……………………………………………………………54 Figure 1-3: The amyloid hypothesis………………………………..56 Chapter 2: Figure 2-1: Genetic background dependent effects of HF/HC diet on body weight, serum cholesterol and brain Aβ levels…..91 Figure 2-2: Correlation of brain Aβ levels with serum cholesterol in B6-R1.40 mice…………………………………………………93 Figure 2-3: Unaltered APP expression and processing in B6-R1.40 animals on HF/HC diet……………………………………….95 Figure 2-4: Similar brain Apoe levels in B6-R1.40 animals on the HF/HC and LF/LC diets……………………………….97 Figure 2-5: Unique brain gene expression profile in B6-R1.40 mice on the LF/LC and HF/HC diets……………………………….99 Figure 2-6: qRT-PCR verification of a subset of genes identified by microarray…………………………………………………….101 Supplemental Figure 2-1: Gender differences in body weight on HF/HC diet…………………………………………………….104 8 Supplemental Figure 2-2: Genetic background dependant effect of HF/HC diet on brain cholesterol…………………………….106 Supplemental Figure 2-3: Correlation of brain Aβ levels with body weight in individual R1.40 lines……………………………..108 Supplemental Figure 2-4: Correlation of brain Aβ with fasted serum cholesterol in R1.40 animals………………………………..110 Chapter 3: Figure 3-1: Region identified in QTL mapping correlates with B6.D2.2D congenic interval………………………………...138 Figure 3-2: B6.D2.2D congenic interval does not alter APP processing…………………………………………………….140 Figure 3-3: B6.D2.2D congenic interval on chromosome 2 does not alter steady state Aβ levels………………………………….142 Figure 3-4: D2 congenic interval of mouse chromosome 2 reduces Aβ deposition………………………………………………….144 Figure 3-5: Absence of the C5a receptor does not alter APP processing…………………………………………………….146 Figure 3-6: Absence of C5a receptor does not alter steady state Aβ levels…………………………………………………………..148 Figure 3-7: Absence of the C5a receptor reduces Aβ deposition in the R1.40 mouse model of AD……………………………...150 Figure 3-8: Absence of C5a receptor reduces Aβ deposition in the APPPS1 mouse model of AD……………………………….152 9 Chapter 4: Figure 4-1: Analysis of the congenic R1.40 mouse model of AD.……………………………………………………………..181 Figure 4-2: Steady state Aβ levels are increased in the B6.A-R1.40 consomic strains compared with the B6-R1.40 controls…………………………………………….183 Figure 4-3: Brain Aβ deposition reduced in the presence of A11 chromosome………………………………………………….185 Figure 4-4: APP processing is unaltered in the B6.A11-APPPS1 consomic animals…………………………………………….187 Figure 4-5: B6.D2.1D and B6.D2.7D congenic regions are not associated with reduced steady state Aβ levels…………..189 Figure 4-6: Aβ deposition reduced in B6.D2.1D congenic animals………………………………………………………...191 Figure 4-7: APP processing is unaltered in the B6.D2.1D congenic strain…………………………………………………………...193 10 ACKNOWLEDGEMENTS Being a student with the unique opportunity of starting graduate school in one lab and finishing in another, I have had an enriched graduate experience and have so many people to thank. I will begin by acknowledging people who have supported my scientific endeavors within the laboratory. First and foremost, I would like to thank my current advisor, Bruce Lamb, for taking me on as a graduate student mid-program, after my first mentor moved to Washington. His dedication to the fight against Alzheimer’s disease is inspirational. I am grateful for the opportunity to train with Bruce and will value him as a colleague throughout my scientific career. I would next like to thank Guixiang Xu, who has been an immeasurable help to me in the Lamb lab. I appreciate her scientific help as well as her loyal friendship. To Kiran Bhaskar, who has served as a mentor and a friend, you are always there to help, no matter the problem. I will miss our lively scientific discussions. To Davis Ryman, thank you for being an attentive and supportive baymate and friend. To all the other member of the Lamb lab, past and present who have provided assistance throughout my time in the lab, Brenda Mayne, Laura Kulnane, Karen Mann, Emily Lehman, Yuan Gao, Niki Kokako-Cochran, Megan Konerth, Yutaro Komuro, Nicole Maphis, Nick Varvel and Sungho Lee, I thank you. I’d also like to thank my first lab, where I spent the first two years of my graduate career and who really gave me the desire, confidence and opportunity to begin graduate school. To the bright and shining Terry Hassold, who was always ready with a pat on the back and a vote of confidence, you made 11 research fun, you made me want to make you proud, thank you. To his lovely wife Pat, who was always there to provide scientific support, thank you. You are the kindest couple in research and I am so grateful for the time we had. To the members of the Hunt/Hassold lab, especially Kara Koehler, Jodi Jackson, Martha Sujario and Petrice Brown, as well as to Brenda in the Willard lab and Michele in the Schwartz lab, I thank you for your support both scientific and moral. This was a really wonderful time in my scientific career, you are all greatly missed. To Joe Nadeau, the Chairman of the Genetics Department, I thank you for your kindness in making the decision to stay behind easy. To Hua Lou and Anne Matthew, the genetics graduate student advisors; I thank you for all of your assistance through the years. Thank you to all of the support staff in the Genetics Department at CWRU as well as in the Neuroscience Department at CCF, Clarice Young, Malana Bey, Dianne Austin, Michele Bey, Michele Yanick, Carol Haney and Eleanor Goldfarb who have been invaluable resources over the years. Finally, I would like to thank my committee members, Mitch Drumm, Gary Landreth, Anna Mitchell and Mark Palmert, for their guidance and support through the years. I’ve really cherished my time at the CWRU Genetics Department. Now I must acknowledge a number of people who have supported my graduate career in other ways. First, to my husband, Michael, he is always on my side, always believes I will persevere and always puts things in perspective for me, for his love and support I am forever thankful. To my children, my best accomplishments, I hope I have been a good role model for you and help you 12 realize you can accomplish your dreams. Coming home to my family has made every day a blessing. To my parents, Carl and Diane Schrump, who have been wonderful role models, balancing a happy family life with graduate careers in education, you have provided me with a lifetime of love and have always believed I could do anything, to you I am forever grateful. To my brother Tom who is always available for advice and support, thank you. A very special thanks to my sister Terri, who has helped me in so many ways I will never be able to repay you, your strength has been an inspiration. To my Mother-in-law and Father-in-law and all of my sister-in-laws and brother-in-laws, who are always there with warm words of encouragement, thank you. My family has been my greatest cheering section, with constant encouragement and an undying belief in me, without them I would never have been able to do this.
Recommended publications
  • Dehydrogenase Gene of Entamoeba Histolytica
    Proc. Nad. Acad. Sci. USA Vol. 89, pp. 10188-10192, November 1992 Medical Sciences Cloning and expression of an NADP+-dependent alcohol dehydrogenase gene of Entamoeba histolytica (amebiasis/protozoan parasite/fermentation/inhibitors) AJIT KUMAR*, PEI-SHEN SHENtt, STEVEN DESCOTEAUX*, JAN POHL§, GORDON BAILEYt, AND JOHN SAMUELSON*1II *Department of Tropical Public Health, Harvard School of Public Health, Boston, MA 02115; tDepartment of Biochemistry, Morehouse School of Medicine, Atlanta, GA 30310; §Microchemical Facility, Emory University, Atlanta, GA 30322; and 'Department of Pathology, New England Deaconess Hospital, Boston, MA 02215 Communicated by Elkan Blout, June 29, 1992 (receivedfor review May 1, 1992) ABSTRACT Ethanol is the major metabolic product of NAD(P)+ so that the reducing equivalents are regenerated glucose fermentation by the protozoan parasite Entmoeba (4-7). Both NADP+-dependent and NAD+-dependent alco- histolytica under the anaerobic conditions found in the lumen hol dehydrogenase (ADH) activities have been identified in of the colon. Here an internal peptide sequence determined E. histolytica trophozoites (4-7). The NADP+-dependent from a major 39-kDa amoeba protein isolated by isoeLtric ADH (EhADHi; EC 1.1.1.2) was found to be composed of focusing followed by SDS/PAGE was used to clone the gene for four -30-kDa subunits, prefer secondary alcohols to primary the E. histolytica NADP+-dependent alcohol dehydrogenase alcohols, and be inhibited by the substrate analogue pyrazole (EhADH1; EC 1.1.1.2). The EhADHi clone had an open (7). The amoeba NAD+-dependent ADH (EC 1.1.1.1) is not reading frame that was 360 amino acids long and encoded a well-characterized (4).
    [Show full text]
  • Genome-Wide Association Study of Increasing Suicidal Ideation During Antidepressant Treatment in the GENDEP Project
    The Pharmacogenomics Journal (2012) 12, 68–77 & 2012 Macmillan Publishers Limited. All rights reserved 1470-269X/12 www.nature.com/tpj ORIGINAL ARTICLE Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project NPerroud1,2,3,RUher1, Suicidal thoughts during antidepressant treatment have been the focus of 1 2,3,4 several candidate gene association studies. The aim of the present genome- MYM Ng , M Guipponi , wide association study was to identify additional genetic variants involved in 5 6 JHauser, N Henigsberg , increasing suicidal ideation during escitalopram and nortriptyline treatment. WMaier7,OMors8, A total of 706 adult participants of European ancestry, treated for major M Gennarelli9, M Rietschel10, depression with escitalopram or nortriptyline over 12 weeks in the Genome- DSouery11, MZ Dernovsek12, Based Therapeutic Drugs for Depression (GENDEP) study were genotyped 13 14 with Illumina Human 610-Quad Beadchips (Illumina, San Diego, CA, USA). AS Stamp ,MLathrop , A total of 244 subjects experienced an increase in suicidal ideation AFarmer1, G Breen1,KJAitchison1, during follow-up. The genetic marker most significantly associated with CM Lewis1,IWCraig1 increasing suicidality (8.28 Â 10À7) was a single-nucleotide polymorphism and P McGuffin1 (SNP; rs11143230) located 30 kb downstream of a gene encoding guanine deaminase (GDA) on chromosome 9q21.13. Two suggestive drug-specific 1MRC Social, Genetic and Developmental Psychiatry associations within KCNIP4 (Kv channel-interacting protein 4; chromosome Centre, Institute of Psychiatry, King’s College 4p15.31) and near ELP3 (elongation protein 3 homolog; chromosome London, London, UK; 2Department of Psychiatry, 8p21.1) were found in subjects treated with escitalopram.
    [Show full text]
  • Identification of the Binding Partners for Hspb2 and Cryab Reveals
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 2013-12-12 Identification of the Binding arP tners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non- Redundant Roles for Small Heat Shock Proteins Kelsey Murphey Langston Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Microbiology Commons BYU ScholarsArchive Citation Langston, Kelsey Murphey, "Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins" (2013). Theses and Dissertations. 3822. https://scholarsarchive.byu.edu/etd/3822 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston A thesis submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Master of Science Julianne H. Grose, Chair William R. McCleary Brian Poole Department of Microbiology and Molecular Biology Brigham Young University December 2013 Copyright © 2013 Kelsey Langston All Rights Reserved ABSTRACT Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactors and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston Department of Microbiology and Molecular Biology, BYU Master of Science Small Heat Shock Proteins (sHSP) are molecular chaperones that play protective roles in cell survival and have been shown to possess chaperone activity.
    [Show full text]
  • The Failure of Two Major Formaldehyde Catabolism Enzymes (ADH5 and ALDH2) Leads to Partial Synthetic Lethality in C57BL/ 6 Mice Jun Nakamura1,2*, Darcy W
    Nakamura et al. Genes and Environment (2020) 42:21 https://doi.org/10.1186/s41021-020-00160-4 SHORT REPORT Open Access The failure of two major formaldehyde catabolism enzymes (ADH5 and ALDH2) leads to partial synthetic lethality in C57BL/ 6 mice Jun Nakamura1,2*, Darcy W. Holley3, Toshihiro Kawamoto4 and Scott J. Bultman3 Abstract Background: Exogenous formaldehyde is classified by the IARC as a Category 1 known human carcinogen. Meanwhile, a significant amount of endogenous formaldehyde is produced in the human body; as such, formaldehyde-derived DNA and protein adducts have been detected in animals and humans in the absence of major exogenous formaldehyde exposure. However, the toxicological effects of endogenous formaldehyde on individuals with normal DNA damage repair functions are not well understood. In this study, we attempted to generate C57BL/6 mice deficient in both Adh5 and Aldh2, which encode two major enzymes that metabolize endogenous formaldehyde, in order to understand the effects of endogenous formaldehyde on mice with normal DNA repair function. Results: Due to deficiencies in both ADH5 and ALDH2, few mice survived past post-natal day 21. In fact, the survival of pups within the first few days after birth was significantly decreased. Remarkably, two Aldh2−/−/Adh5−/− mice survived for 25 days after birth, and we measured their total body weight and organ weights. The body weight of Aldh2−/−/Adh5−/− mice decreased significantly by almost 37% compared to the Aldh2−/−/Adh5+/− and Aldh2−/−/Adh5+/+ mice of the same litter. In addition, the absolute weight of each organ was also significantly reduced. Conclusion: Mice deficient in both formaldehyde-metabolizing enzymes ADH5 and ALDH2 were found to develop partial synthetic lethality and mortality shortly after birth.
    [Show full text]
  • AKAP8L Rabbit Polyclonal Antibody – TA329433 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA329433 AKAP8L Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: WB Recommended Dilution: WB Reactivity: Human Host: Rabbit Isotype: IgG Clonality: Polyclonal Immunogen: The immunogen for Anti-AKAP8L antibody is: synthetic peptide directed towards the C- terminal region of Human AKAP8L. Synthetic peptide located within the following region: NNKLISKKLERYLKGENPFTDSPEEEKEQEEAEGGALDEGAQGEAAGISE Formulation: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. Note that this product is shipped as lyophilized powder to China customers. Purification: Affinity Purified Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 64 kDa Gene Name: A-kinase anchoring protein 8 like Database Link: NP_055186 Entrez Gene 26993 Human Q9ULX6 Background: AKAP8L could play a role in constitutive transport element (CTE)-mediated gene expression. It does not seem to be implicated in the binding of regulatory subunit II of PKA. It may be involved in nuclear envelope breakdown and chromatin condensation. It may regulate the initiation phase of DNA replication when associated with TMPO-beta. Synonyms: HA95; HAP95; NAKAP; NAKAP95 This product is to be used for laboratory only. Not for diagnostic
    [Show full text]
  • Prion Fragment Peptides Are Digested with Membrane Type Matrix Metalloproteinases and Acquire Enzyme Resistance Through Cu2+-Binding
    Biomolecules 2014, 4, 510-526; doi:10.3390/biom4020510 OPEN ACCESS biomolecules ISSN 2218-273X www.mdpi.com/journal/biomolecules/ Article Prion Fragment Peptides Are Digested with Membrane Type Matrix Metalloproteinases and Acquire Enzyme Resistance through Cu2+-Binding Aya Kojima 1,2, Motomi Konishi 1 and Toshifumi Akizawa 1,* 1 Analytical Chemistry, Pharmaceutical Science, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan; E-Mails: [email protected] (A.K.); [email protected] (M.K.) 2 Division of Cellular and Molecular Biology, Department of Cancer Biology, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 180-8639, Japan * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel./Fax: +81-72-866-3129. Received: 31 January 2014; in revised form: 2 April 2014 / Accepted: 11 April 2014 / Published: 8 May 2014 Abstract: Prions are the cause of neurodegenerative disease in humans and other mammals. The structural conversion of the prion protein (PrP) from a normal cellular protein (PrPC) to a protease-resistant isoform (PrPSc) is thought to relate to Cu2+ binding to histidine residues. In this study, we focused on the membrane-type matrix metalloproteinases (MT-MMPs) such as MT1-MMP and MT3-MMP, which are expressed in the brain as PrPC-degrading proteases. We synthesized 21 prion fragment peptides. Each purified peptide was individually incubated with recombinant MT1-MMP or MT3-MMP in the presence or absence of Cu2+ and the cleavage sites determined by LC-ESI-MS analysis. Recombinant MMP-7 and human serum (HS) were also tested as control.
    [Show full text]
  • Use of Genomic Tools to Discover the Cause of Champagne Dilution Coat Color in Horses and to Map the Genetic Cause of Extreme Lordosis in American Saddlebred Horses
    University of Kentucky UKnowledge Theses and Dissertations--Veterinary Science Veterinary Science 2014 USE OF GENOMIC TOOLS TO DISCOVER THE CAUSE OF CHAMPAGNE DILUTION COAT COLOR IN HORSES AND TO MAP THE GENETIC CAUSE OF EXTREME LORDOSIS IN AMERICAN SADDLEBRED HORSES Deborah G. Cook University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Cook, Deborah G., "USE OF GENOMIC TOOLS TO DISCOVER THE CAUSE OF CHAMPAGNE DILUTION COAT COLOR IN HORSES AND TO MAP THE GENETIC CAUSE OF EXTREME LORDOSIS IN AMERICAN SADDLEBRED HORSES" (2014). Theses and Dissertations--Veterinary Science. 15. https://uknowledge.uky.edu/gluck_etds/15 This Doctoral Dissertation is brought to you for free and open access by the Veterinary Science at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Veterinary Science by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Age-Dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver S
    Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2017/08/21/dmd.117.076463.DC2 http://dmd.aspetjournals.org/content/suppl/2017/06/12/dmd.117.076463.DC1 1521-009X/45/9/1044–1048$25.00 https://doi.org/10.1124/dmd.117.076463 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 45:1044–1048, September 2017 Copyright ª 2017 by The American Society for Pharmacology and Experimental Therapeutics Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver s Deepak Kumar Bhatt, Andrea Gaedigk, Robin E. Pearce, J. Steven Leeder, and Bhagwat Prasad Department of Pharmaceutics, University of Washington, Seattle, Washington (D.K.B., B.P.); Department of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children’s Mercy-Kansas City, Missouri and School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri (A.G., R.E.P., J.S.L.) Received April 21, 2017; accepted June 5, 2017 ABSTRACT Hepatic cytosolic alcohol and aldehyde dehydrogenases (ADHs and the adult levels, respectively. For all proteins, the abundance steeply ALDHs) catalyze the biotransformation of xenobiotics (e.g., cyclo- increased during the first year of life, which mostly reached adult Downloaded from phosphamide and ethanol) and vitamin A. Because age-dependent levels during early childhood (age between 1 and 6 years). Only for hepatic abundance of these proteins is unknown, we quantified ADH1A protein abundance in adults (age > 18 year) was ∼40% lower protein expression of ADHs and ALDH1A1 in a large cohort of pediatric relative to the early childhood group. Abundances of ADHs and and adult human livers by liquid chromatography coupled with tandem ALDH1A1 were not associated with sex in samples with age > 1 year mass spectrometry proteomics.
    [Show full text]
  • ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease
    International Journal of Molecular Sciences Review ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease Francesca Tosetti 1,* , Massimo Alessio 2, Alessandro Poggi 1,† and Maria Raffaella Zocchi 3,† 1 Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico S. Martino Largo R. Benzi 10, 16132 Genoa, Italy; [email protected] 2 Proteome Biochemistry, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; [email protected] 3 Division of Immunology, Transplants and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work as last author. Abstract: Enzymes, once considered static molecular machines acting in defined spatial patterns and sites of action, move to different intra- and extracellular locations, changing their function. This topological regulation revealed a close cross-talk between proteases and signaling events involving post-translational modifications, membrane tyrosine kinase receptors and G-protein coupled recep- tors, motor proteins shuttling cargos in intracellular vesicles, and small-molecule messengers. Here, we highlight recent advances in our knowledge of regulation and function of A Disintegrin And Metalloproteinase (ADAM) endopeptidases at specific subcellular sites, or in multimolecular com- plexes, with a special focus on ADAM10, and tumor necrosis factor-α convertase (TACE/ADAM17), since these two enzymes belong to the same family, share selected substrates and bioactivity. We will discuss some examples of ADAM10 activity modulated by changing partners and subcellular compartmentalization, with the underlying hypothesis that restraining protease activity by spatial Citation: Tosetti, F.; Alessio, M.; segregation is a complex and powerful regulatory tool.
    [Show full text]
  • Using Evolutionary Conserved Modules in Gene Networks As a Strategy to Leverage High Throughput Gene Expression Queries Jeanne M
    Ecology, Evolution and Organismal Biology Ecology, Evolution and Organismal Biology Publications 9-2010 Using Evolutionary Conserved Modules in Gene Networks as a Strategy to Leverage High Throughput Gene Expression Queries Jeanne M. Serb Iowa State University, [email protected] Megan C. Orr Iowa State University M. Heather West Greenlee Iowa State University, [email protected] Follow this and additional works at: http://lib.dr.iastate.edu/eeob_ag_pubs Part of the Ecology and Evolutionary Biology Commons, Genetics Commons, and the Systems Biology Commons The ompc lete bibliographic information for this item can be found at http://lib.dr.iastate.edu/ eeob_ag_pubs/19. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Article is brought to you for free and open access by the Ecology, Evolution and Organismal Biology at Iowa State University Digital Repository. It has been accepted for inclusion in Ecology, Evolution and Organismal Biology Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Using Evolutionary Conserved Modules in Gene Networks as a Strategy to Leverage High Throughput Gene Expression Queries Abstract Background: Large-scale gene expression studies have not yielded the expected insight into genetic networks that control complex processes. These anticipated discoveries have been limited not by technology, but by a lack of effective strategies to investigate the data in a manageable and meaningful way. Previous work suggests that using a pre-determined seednetwork of gene relationships to query large-scale expression datasets is an effective way to generate candidate genes for further study and network expansion or enrichment.
    [Show full text]
  • 1) (As of December 2018) and the Latest GWAS of AD (2
    SUPPLEMENTARY FIGURES downstream intergenic ncRNA_exonic upstream ●936 ●918 group downstream intergenic ncRNA_exonic upstream group exonic exonicintronicintronic ncRNA_intronic ncRNA_intronicUTR3 UTR3 3.8% 1.2%1.5%1.9% 3.8% 5.4%5.4% 750 0.3% 3.8%1.2%1.5%1.9% ●700 5.4% ●670 0.3% 500 45.8% 40.240.2% % 45.8% ●329 ●274 250 ●223 Number (GWAS SNPs/studies) Number (GWAS ●128 ●105 45.8% ●54 ●57 ●58 ●48 ●42 ●46 ●50 ●30 ●3740.2% ● ●17 ●25 ●4 ●6 ●12 0 ● 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Year Supplementary Figure S1. GWAS of AD since 2007. The figure is based on data from the GWAS Catalog (1) (as of December 2018) and the latest GWAS of AD (2). The green area shows the total number of AD-associated SNPs, and the purple area shows the total number of GWAS of AD. The insert chart shows the proportions of different types of all 936 AD-associated SNPs. 1 100 200 RPS27A TGFB2 BIN1 C4BPB MSH2 PROC UGT1A1 RAB1A TTN DISC1 50 PDCL3 COL4A3 CD55 ERCC3 100 USP21 C4BPA ITSN2 PTPRF MPZ FMN2 INPP5D CEP85 FNBP1L CSF1 CD46 ADAMTS4 PRKRA SPRED2 0 CTNNA2 DGKD ADCY10 ZAP70 LIMS2 PDE1A PROX1 0 CHRNB2 CR1 HSPG2 SH3BGRL3 DAB1 CTBS FCER1G MAP3K2 AD risk score or log10(P value) IL6R CDC73 CD34 AD risk score or log10(P value) −50 B4GALT3 IL19 0 50 100 150 200 250 0 50 100 150 200 Chromosome 1 (Mb) Chromosome 2 (Mb) ATP2B2 LTF ARF4 MECOM PAK2 EPHB1 40 VHL PRSS42 ARL6IP5 150 COL25A1 TDGF1 RPSA CCR2 CCR1 IL1RAP IRAK2 20 PTPRG 100 FLNB TF CX3CR1 IL17RD SH3RF1 FGG FANCD2 LIMD1 CCR5 50 0 WDR1 PDGFRA EIF4E FGB AD risk score or log10(P value) AD risk
    [Show full text]